Global Respiratory Care Devices Market to Reach US$49.13


Pune, June 20, 2022 (GLOBE NEWSWIRE) — According to a recent study published by Growth Plus Reports, the demand for the global market respiratory care devices market is expected to reach approximately US$ 49.13 billion by 2031. Factors such as increasing prevalence of chronic respiratory diseases and introduction of advanced respiratory diseases play a key role in the growth of the market.

Growth engines

Technological advancements have ushered in new ways of delivering healthcare by creating ease for patients and healthcare professionals. The integration of advanced products is a boon to boost the respiratory care devices market.

Many health care companies have devoted themselves to the development and launch of new products that will help diagnose disease easier and faster. There are several digital devices launched by companies that help monitor and increase patient adherence to treatments and, therefore, improve patient outcomes.

Companies like ResMed are focused on creating smart therapy solutions enabled by data analytics, AI, ML and sensor technologies, which will help improve patient care. For example, in 2020 ResMed launched Mobi – a portable oxygen concentrator. Mobi provides an optimal balance of oxygen delivery, weight, and battery life, so people with COPD or other chronic conditions can get oxygen therapy wherever they go.

The launch of these cutting-edge products is helping to transform the delivery of respiratory care.

The global respiratory care devices market has been analyzed from four angles: product, application, end users and region.

For critical Respiratory Care Devices Market insights, request a sample report

Excerpts from ‘Segmentation by product’

On the basis of product, the respiratory care devices market has been segmented into:-

  • Therapeutic devices
  • Diagnostic devices
  • Monitoring devices
  • Consumables & Accessories.

Therapeutic Devices segment is further sub-segmented into Ventilators (ICU Ventilators and Portable Ventilators), Positive Airway Pressure (PAP) Devices (Automatic Positive Airway Pressure (APAP) Device, Bi-Level Positive Airway Pressure (BiPAP) Device and continuous positive airway pressure (CPAP), oxygen concentrators, nebulizers, humidifiers, reusable resuscitators, inhalers and oxygen hoods.

The therapeutic device segment held the largest market share in 2020.

The increase in the prevalence rate and mortality associated with serious respiratory conditions has led to an increase in the demand for devices such as PAPs, ventilators, nebulizers and oxygen concentrators. This is driving the growth of the therapeutic devices segment.

Excerpts from ‘Segmentation by region’

Regionally, Asia Pacific is expected to grow at a higher CAGR during the forecast period.

Factors attributing to the growth of this segment include increase in healthcare spending, increase in medical tourism, and increase in private-public financing.

Additionally, new product launches have played a key role in driving the respiratory care devices market in the region.

For example, in August 2020, Honeywell International Inc. established production of N95 masks in India. The company planned to produce up to 2 million disposable masks per month at its Fulgaon manufacturing facility in Pune, India. Similarly, in November 2019, Lupine launched ‘Adhero’, a one-of-a-kind smart device launched in India to track patients’ metered-dose inhaler (MDI) usage pattern. This device is a reusable device with built-in sensors to track daily usage and consumption pattern.

Excerpts from “Competitive Landscape”

Key Players operating in the Global Respiratory Care Devices Market include:-

  • Koninklijke Philips NV
  • ResMed
  • Masimo
  • Medtronic
  • General electricity company
  • Air Liquide Medical Systems
  • Drägerwerk AG & Co. KGaA
  • Getinge AB
  • Fisher & Paykel Healthcare Limited
  • Hamilton Medical
  • Among others

Find out before you buy the report:



1.1. Market ecosystem
1.2. Geographic scope
1.3. Schedule under study
1.3.1. Historical years – 2018 and 2019
1.3.2. Base year – 2020
1.3.3. Planned years – 2021 to 2031
1.4. Currency used in the report

2.1. Research approach
2.2. Data collection methodology
2.3. Information source
2.3.1. Secondary sources
2.3.2. Primary sources
2.4. Market estimation approach
2.4.1. From bottom to top
2.4.2. From top to bottom
2.5. Market Forecast Model
2.6. Limits and assumptions

3.1. Current market trend (COVID-19 outlook)

4.1. Drivers
4.2. Constraints
4.3. Opportunities

5.1. Therapeutic devices
5.1.1. Fans Intensive care ventilators Portable fans
5.1.2. Positive airway pressure (PAP) devices Automatic Positive Airway Pressure Device (APAP) Bi-Level Positive Airway Pressure Device (BiPAP) Continuous Positive Airway Pressure (CPAP) Device
5.1.3. Oxygen concentrators
5.1.4. Nebulizers
5.1.5. Humidifiers
5.1.6. Reusable resuscitators
5.1.7. Inhalers
5.1.8. Oxygen hoods


  • Fueled by free analyst hours and expert interviews with every report
  • Comprehensive quantitative and qualitative information at segment and sub-segment level
  • Trends and perspectives of the impact of Covid 19
  • Granular information at global/regional/country level
  • In-depth insights into market dynamics (drivers, restraints, opportunities) and business environment
  • Global coverage of the competitive landscape
  • Winning imperatives
  • Comprehensive coverage of “strategic developments” recorded by major market players


  • Distributor Landscape Assessment
  • Pricing information
  • Customer evaluation
  • Analysis of investments and initiatives
  • ‘Company Profile’ of key players

Buy this Premium Research Report @

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge services company. We are proud members of the EPhMRA (European Pharmaceutical Marketing Research Association).

The Growth+ portfolio of services leverages our core capabilities in secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and game-changing solutions. that prepare them for future growth and success.

We have been recognized by the prestigious CEO Magazine as “2020’s Most Innovative Healthcare Market Research Company”.


Comments are closed.